Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited.

Vaccine - 17 Nov 2006

Nylén Susanne, Khamesipour Ali, Mohammadi Akram, Jafari-Shakib Reza, Eidsmo Liv, Noazin Sassan, Modabber Farrokh, Akuffo Hannah

Abstract excerpt

BACKGROUND: In the screening of vaccine candidates it is important to select candidates that evoke immune responses associated with protection. Valid surrogate markers against human leishmaniasis are still lacking. METHODS: A controlled injection of live Leishmania known as leishmanization, (LZ),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adjuvants, Immunologic
Share to Antigens, Protozoan
Share to Double-Blind Method

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endemic Diseases

Share to Leishmania major

Share to Leishmaniasis, Cutaneous

Share to Mycobacterium bovis

Share to Skin Tests

Source

Identifiers

PMID: 17049693
DOI: 10.1016/j.vaccine.2006.05.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17049693-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited.PMID 17049693Read ↗

Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.Semantic proximity Read ↗

CCL19-CCR7 mediated recruitment of T cells is associated with the leishmanin skin test in individuals with prior exposure to <i>Leishmania</i> parasitesSemantic proximity Read ↗

Vaccine candidates, immuno-dominant antigens, and potent vaccine adjuvants for preventing cutaneous leishmaniasis: a sysSemantic proximity Read ↗

Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discoverySemantic proximity Read ↗

Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by <i>Leishmania donovani</i>Semantic proximity Read ↗

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotidesSemantic proximity Read ↗

Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani.Semantic proximity Read ↗

Intradermal Synthetic DNA Vaccination Generates Leishmania -Specific T Cells in the Skin and Protection against Leishmania majorSemantic proximity Read ↗

Leishmaniasis: Current Status of Vaccine DevelopmentSemantic proximity Read ↗

Safety, immunogenicity, and efficacy of a gentamicin-attenuated Leishmania major vaccine in an open-label clinical vaccine trialSemantic proximity Read ↗

Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human DiseaseSemantic proximity Read ↗

Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.